Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00390_DB06212_nanopub.RA5_RhfDKin1HLYcpVHvuSmdS-bdPgMWDksfitdnWnWtg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00390_DB06212 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00390_DB06212 label "DDI between Digoxin and Tolvaptan - Tolvaptan increases serum digoxin concentrations due to competitive inhibition of P-glycoprotein in the liver, intestine, and kidney. P-glycoprotein facilitates digoxin efflux thus inhibition of this protein will increase incidence of adverse effects. [drugbank_resource:DB00390_DB06212]" assertion.
- drugbank_resource:DB00390_DB06212 identifier "drugbank_resource:DB00390_DB06212" assertion.
- drugbank_resource:DB00390_DB06212 title "DDI between Digoxin and Tolvaptan - Tolvaptan increases serum digoxin concentrations due to competitive inhibition of P-glycoprotein in the liver, intestine, and kidney. P-glycoprotein facilitates digoxin efflux thus inhibition of this protein will increase incidence of adverse effects." assertion.
- drugbank:DB00390 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00390_DB06212 assertion.
- drugbank:DB06212 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00390_DB06212 assertion.